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We herein report a case of radical nephroureterectomy and replacement of the inferior 
vena cava (IVC) with ahuman cadaveric aortic graft for a patient with renal pelvis tran-
sitional cell carcinoma associated with IVC infiltration. In advanced disease, radical 
surgery is essential to achieve long-term survival. This case entails the use of another 
treatment option among the numerous options currently available for the management 
of patients with advanced renal cancer associated with IVC invasion.
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Primary transitional cell carcinoma of the renal pelvis or 
ureter is a relatively rare condition. It accounts for less than 
1% of genitourinary neoplasms and 5 to 7% of all urinary 
tract tumors [1,2]. Extension of transitional cell carcinomas 
into the vena cava is rarely reported in the literature [3]. 
Most data available are derived from retrospective studies, 
and surgery is the mainstay of treatment. Aggressive sur-
gery to remove an inferior vena cava (IVC) thrombus is re-
ported to be effective in prolonging survival in patients with 
renal cell carcinoma (RCC) [3,4]. However, the value of ag-
gressive surgery in the treatment of transitional cell carci-
noma of the renal pelvis remains unclear owing to limited 
evidence and the aggressive course of the condition. In the 
case of IVC invasion, complete resection is necessary, but 
IVC resection presents a technical challenge.
In cases requiring surgical reconstruction, prosthetic re-
placement has been found to be feasible and safe. The mate-
rial of choice is polytetrafluoroethylene (PTFE), as re-
ported previously [5,6]. Human cadaveric aortic grafts, or 
cryopreserved aorta, could be an option, but their use has 
not yet been reported for the restoration of caval continuity. 
We herein report a case of radical nephroureterectomy 
with IVC replacement with a human cadaveric aortic graft 
for a patient with renal pelvis transitional cell carcinoma 
with IVC invasion.
CASE REPORT
A 67-year-old man presented to our clinic with a 3-month 
history of dull pain in the right flank. He denied having ex-
perienced other symptoms. He had no remarkable past 
medical or family history. Physical examination elicited 
mild right costovertebral angle tenderness. Urine analy-
sis, complete blood count, and routine blood chemistry re-
sults were unremarkable and urine cytology showed atyp-
ical cells. Abdominal computed tomography (CT) demon-
strated that most of the right kidney was occupied by a huge 
irregular tumor measuring 8 cmx6.5 cmx6.5 cm in size (Fig. 
1A, B). The tumor exhibited heterogeneous enhancement 
and areas of necrosis. The right perirenal space exhibited 
strand-like infiltration and the right renal fascia was 
thickened. The tumor had invaded into the right renal vein 
and possibly the IVC. The right upper ureter experienced 
tumor invasion. Multiple, enlarged, para-aortic lymph no-
des were seen. Under the impression of a renal pelvis tu-
mor, we subsequently performed a right radical nephrour-
eterectomy with replacement of the IVC with a human ca-
daveric aortic graft. The tumor was mobilized en bloc with Korean J Urol 2012;53:285-287
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FIG. 1. (A) Vertical and (B) axial 
computed tomography images show-
ing a large (8 cmx6.5 cm) irregular 
mass. (C) The 9-month follow-up image
of the patient confirmed no recurrence 
and a patent cadaveric aorticgraft.
FIG. 2. Intraoperative findings after caval replacement with a 
cadaveric aortic graft.
FIG. 3. Microscopic findings showing tumor cells infiltrating the 
inferior vena cava wall (H&E, x100).
the right kidney, adrenal gland, ureter, and regional lymph 
node. The right renal artery was divided and clamped on 
the left side of the IVC. The IVC was then clamped prox-
imally, contralaterally, and distally and was resected for 
an extension of 12 cm in length. The vascular defect was 
then repaired with the cadaveric aortic graft (Fig. 2).
Grossly, a huge, grayish, solid tumor measuring 8.1 
cmx6.5 cm in dimension was seen involving the whole renal 
pelvis and calyces. The tumor had invaded the renal paren-
chymal, perinephric, and peripelvic fat. Renal vein and IVC 
involvement were also identified (Fig. 3). Microscopically, 
the renal tumor was classified as grade III transitional cell 
carcinoma (World Health Organization classification) and 
comprised neoplastic cells arranged in irregular solid nests 
associated with marked tumor necrosis. The two dissected 
hilar lymph nodes harbored carcinoma metastasis. The pa-
tient was discharged on the eighth postoperative day and 
anticoagulant therapy was initiated, which was continued 
for 9 months. There was no sign of recurrence at 9 months 
after the operation (Fig. 1C).
DISCUSSION
Invasion of the renal vein and IVC by RCC is commonly 
described. However, venous infiltration by transitional cell Korean J Urol 2012;53:285-287
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carcinoma of the renal pelvis remains rarely reported [1-3]. 
Few renal pelvic tumors extend into the IVC, and it is very 
rare that they invade the wall of the IVC [3]. 
Earlier presentation of many of these transitional cell le-
sions due to hematuria may be partly responsible [1]. When 
a patient presents with signs and symptoms such as low-
er-extremity edema, varicocele, albuminuria, pulmonary 
embolism, or urographic dysfunction of the involved kid-
ney, tumor extension into the IVC should be suspected be-
fore removing the renal tumor [1-5]. Nevertheless, the ma-
jority of patients with extension of tumor into the renal vein 
and IVC are asymptomatic, and the diagnosis is usually 
made radiologically [1-3,7]. 
In the case of tumor invasion of the caval wall, medial venot-
omy carries a higher risk of narrowing after caval wall ex-
cision and renal vein repair and often requires caval wall 
reconstruction. If collateral circulation is not present, IVC re-
section can be associated with severe edema of the lower ex-
tremities [7]. In this setting, reconstructing the IVC should 
be considered and can be performed with a PTFE graft, but 
the main concern with prosthetic grafts for vein replacement 
is higher risks of thrombosis and infection. Therefore, autolo-
gous venous and pericardial grafts are preferred [8].
The operative procedure depends on correct preopera-
tive diagnosis. Urine cytology and brushings from the in-
volved renal pelvis may aid in correct diagnosis, although 
a frozen section of the tumor upon removal of the specimen 
may be necessary to exclude transitional cell carcinoma. 
Similarly to the case of RCC, aggressive surgical treatment 
is indicated in all patients with renal tumors associated 
with IVC invasion, because nephrectomy alone is asso-
ciated with dismal prognosis [3,4]. However, IVC resection 
is an uncommon and challenging procedure. 
Recently, a multitude of advancements have made the IVC 
resection procedure safer. Advances in surgical technique 
and intraoperative monitoring all contribute to improved 
perioperative outcome. Cardiopulmonary bypass may mini-
mize bleeding from the operation field and achieve stable he-
modynamic status during IVC clamping and thus provides 
a bloodless operative field to facilitate tumor resection and 
venous reconstruction in patients with IVC invasion [9]. 
However, cardiopulmonary bypass is the main cause of the 
complex systemic inflammatory response, which leads to ad-
verse postoperative outcomes, including renal, pulmonary, 
and neurological complications [10]. Postoperative bleeding 
and coagulation disturbances are the most frequently re-
ported complications in patients who undergo IVC thrombec-
tomy with nephrectomy. Another technique that may ach-
ieve hemodynamic stability is aortic cross-clamping during 
IVC reconstruction [9]. Even patients without venous occlu-
sion tolerate this procedure without experiencing significant 
hemodynamic instability, and transient hypotension can be 
managed by fluid and blood replacement. 
Different IVC replacement methods have been reported. 
Primary repair or prosthetic or biologic patch angioplasty 
is used in IVC partial resections. When the IVC needs to 
be replaced, PTFE prosthetic grafts are usually used [5,6]. 
Because of low venous pressure, ring-reinforced PTFE 
grafts are often preferred. However, the limits of this 
well-established technique include the risk of prosthetic 
occlusion or infection [5,6]. Aortic graft availability is scant 
because harvesting from multi-organ donors is not a stand-
ard procedure. However, an aortic graft has the advantages 
of being a good size-match to the vascular defect with resist-
ance to infection. The long-term patency of IVC recon-
struction is still in question, because no cases have pre-
viously been reported. Postoperative anticoagulation is not 
commonly described. However, we elected to initiate post-
operative anticoagulation, which continued for 9 months, 
to ensure patency of the aortic graft. 
Long-term follow-up will be necessary to monitor graft 
survival. In this report, the feasibility and safety of the pro-
cedure is documented. If safety, efficacy, and long-term pa-
tency were to be validated, a regular collection of large ves-
sels by donor surgical teams should be encouraged to facili-
tate the conduct of prospective studies.
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